Search

Learn how MSK helps patients receive brain tumor treatment, identify symptoms and signs of brain tumors, and be aware of causes and risk factors.

… If you’ve been diagnosed with a brain tumor, you are facing many decisions — choices that can be overwhelming and hard. Where should you go for care? What’s your first step?  At Memorial Sloan Kettering, our team of experts is dedicated to caring for people with brain tumors and finding new treatments

Our doctors and researchers are constantly seeking new and improved treatments for salivary gland cancer through our program of clinical trials.

… Doctors at Memorial Sloan Kettering are constantly working to improve treatment for salivary gland cancer through research studies called clinical trials. Participating in a clinical trial may give you access to treatments that are not widely available elsewhere. A clinical trial may offer you additional

After diagnosing MDS, MSK doctors will determine which subtype you have. Learn more.

… There are many subtypes of MDS. The subtype is determined using the results of blood and bone marrow tests. (Learn about these tests and how MDS is diagnosed.) MDS subtype is determined using either the World Health Organization (WHO) classification system or the French-American-British (FAB) classification

Our team of gastrointestinal surgeons, endocrinologists, pathologists, and medical oncologists provides comprehensive, personalized care for people with gastrointestinal neuroendocrine tumors.

… The gastrointestinal neuroendocrine tumor team at Memorial Sloan Kettering is a multidisciplinary group of doctors that includes surgeons, medical oncologists, radiation oncologists, endocrinologists, nuclear medicine specialists, interventional radiologists, radiologists, and pathologists. Our team

Hodgkin lymphoma, also known as Hodgkin’s disease, usually begins in a type of B cell that is found in the bone marrow. Learn more about the subtypes of Hodgkin lymphoma.

… Hodgkin lymphoma (Hodgkin’s disease) is an uncommon form of lymphoma. It is distinguished by the presence of large abnormal tumor cells called Hodgkin Reed-Sternberg cells. Although Hodgkin lymphoma can occur in both children and adults, it is usually diagnosed in young adults between 20 and 34. Read

A selection of recent publications related to GVHD research.

… The following is a selection of recent publications related to graft-versus-host disease (GVHD): Harris AC, Markova A, Devlin S, Singh A, Susman P, Brown S, Grasso C, Custodio C, Estilo C, Ibanez K, Myers M, Syrkin G, Yom S, Perales MA, Ponce DM. Establishing a Graft-Versus-Host Disease (GVHD)-Focused

The stage of bile duct cancer (cholangiocarcinoma) is determined by the size of the tumor and whether it has spread beyond the bile duct.

… Bile duct cancer is classified according to the type and stage, from the earliest to the most advanced. The stages of bile duct cancer are based on the location and size of the tumor and how far it has spread. Cancers at similar stages tend to have a similar outlook and are often treated in much the

Symptoms of cancer of unknown primary are usually noticed in the area where the tumor is found, but some people may have no symptoms.

… Symptoms of cancer of unknown primary are usually noticed in the area where the tumor is found. This may be the lungs, liver, bones, or lymph nodes. However, some people have no symptoms. They learn they have cancer after a medical or imaging test for another condition. Others experience symptoms that

Learn about our comprehensive approach to surgery for male breast cancer, including mastectomy, breast-conserving options, and sentinel lymph node biopsy.

… Surgery is the most common treatment for men with breast cancer. About 98 percent of male breast cancer patients are treated with mastectomy (surgical removal of the breast). Mastectomy Today, most male patients are treated by total mastectomy, in which the breast is removed but the chest wall muscles

The Prostate Cancer Clinical Trials Consortium is a national clinical research group sponsored by the Department of Defense, with its coordinating center headquartered at Memorial Sloan Kettering.

… The Prostate Cancer Clinical Trials Consortium (PCCTC) is a network of over 112 participating institutions sponsored by the Prostate Cancer Foundation and the Department of Defense Prostate Cancer Research Program (PCF), with its Coordinating Center headquartered at Memorial Sloan Kettering Cancer Center